Page last updated: 2024-10-16

aminolevulinic acid and Ketron-Goodman Disease

aminolevulinic acid has been researched along with Ketron-Goodman Disease in 1 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Ketron-Goodman Disease: A generalized or disseminated form of pagetoid reticulosis. Some authors consider it to be a primary cutaneous aggressive epidermotrophic CD8+ T-Cell lymphoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mendese, GW1
Beckford, A1
Krejci, N1
Mahalingam, M1
Goldberg, L1
Gilchrest, BA1

Other Studies

1 other study available for aminolevulinic acid and Ketron-Goodman Disease

ArticleYear
Pagetoid reticulosis in a prepubescent boy successfully treated with photodynamic therapy.
    Clinical and experimental dermatology, 2012, Volume: 37, Issue:7

    Topics: Aminolevulinic Acid; Child; Foot Dermatoses; Humans; Male; Pagetoid Reticulosis; Photochemotherapy;

2012